United States S 4152: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Status: Introduced in Senate (as of 2022-05-05)

State: United States · Session: 117 · Bill: S 4152

Sponsors: Mark Kelly, Kyrsten Sinema, Susan M. Collins

View United States S 4152 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.